
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) is an integrated, technology-driven global CDMO platform committed to advancing therapeutics for a healthier world. Our rebranding from Suven Pharma to Cohance marks a bold new chapter—one that reflects our expanded vision and sharpened focus on collaboration and innovation. The name Cohance captures our purpose: to Collaborate with global innovators and Enhance their molecules, helping bring transformative solutions to patients and consumers worldwide.
Annual Revenue$500M to $1B
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.